We have historically outsourced all of the research and clinical development for our programs under a master services agreement with our subsidiaries, Biohaven Pharmaceuticals, Inc. ("BPI") and Bioha…
We have historically outsourced all of the research and clinical development for our programs under a master services agreement with our subsidiaries, Biohaven Pharmaceuticals, Inc. ("BPI") and Bioha…
The Company has entered into agreements with several contract manufacturing organizations ("CMOs") and contract research organizations ("CROs") to provide products and services in connection with the…
The Company has entered into agreements with several contract manufacturing organizations ("CMOs") and contract research organizations ("CROs") to provide products and services in connection with the…
Biohaven Ltd. Customers
No clients on recordNo downstream customers found in our database for Biohaven Ltd..
Biohaven Ltd. Debt Obligations
Instrument
Description
Confidence
Evidence
BHVN-DEBT
Debt stack $286.2M
90%
Market cache reports total debt of $286.2M.
BHVN-DEBT-8186
Warrants outstanding: 3340000
90%
xbrl warrant detail from xbrl 2024-12-31.
Biohaven Ltd. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Biohaven Ltd..
Biohaven Ltd. Ownership
Holder
Name
Confidence
Evidence
BHVN-OWNER-JANUS-HENDERSON-GROUP-PLC
JANUS HENDERSON GROUP PLC
90%
13F overlay lists JANUS HENDERSON GROUP PLC as top holder; 278 tracked holders.
Biohaven Ltd. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
